TXG — 10X Genomics Inc
In 2026 Q2, 5 of the 140 tracked hedge funds reported a position in 10X Genomics Inc (TXG), worth $47.21M combined. Over the quarter 3 opened or added, 4 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $30.75M | 0.04% | -20.5% |
| Duquesne | $15.46M | 0.35% | NEW |
| Quadrature | $739.69K | 0.00% | NEW |
| Caxton Associates | $231.73K | 0.00% | -58.5% |
| Persistent | $28.95K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.